Compound information
- Natural Products
- ZC239093
- Molecular Formula
- C20H29N5O5
- Molecular Weight
- 419.216869028 g/mol
- Structure
-
- IUPAC Name
- methyl (2R)-1-[(2S)-2-(benzyloxycarbonylamino)-5-guanidino-pentanoyl]pyrrolidine-2-carboxylate
- InChI
- InChI=1S/C20H29N5O5/c1-29-18(27)16-10-6-12-25(16)17(26)15(9-5-11-23-19(21)22)24-20(28)30-13-14-7-3-2-4-8-14/h2-4,7-8,15-16H,5-6,9-13H2,1H3,(H,24,28)(H4,21,22,23)/t15-,16+/m0/s1
- InChI Key
- SDSIMCZEPCWUQN-JKSUJKDBSA-N
- SMILES
- COC(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1
- Source
- ZINC000102196765
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 2 |
Heteroatom Count | 10 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 146.84 Å2 | LogP | 0.464 |
LogS | -2.252 | LogD | 0.758 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.025 | Pgp substrate | 0.991 |
HIA | 0.045 | F20 % | 0.909 |
F30 % | 0.0 | Caco-2 | -5.869 |
MDCK | -5.308 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.085 | PPB | 50.477 |
VD | 0.631 | Fu | 0.121 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.62 |
CYP2A6 substrate | 0.391 | CYP2B6 substrate | 0.532 |
CYP2C19 inhibitor | 0.097 | CYP2C19 substrate | 0.785 |
CYP2C8 substrate | 0.58 | CYP2C9 inhibitor | 0.228 |
CYP2C9 substrate | 0.421 | CYP2D6 inhibitor | 0.011 |
CYP2D6 substrate | 0.901 | CYP2E1 substrate | 0.342 |
CYP3A4 inhibitor | 0.057 | CYP3A4 substrate | 0.972 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.739 | CL | 3.47 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.256 | Hepatotoxicity | 0.2 |
Mutagenicity | 0.016 | Rat Oral Acute Toxicity | 0.078 |
FDAMDD | 0.49 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.195 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.19 | IGC50 | 2.225 |
LC50FM | 1.47 | LC50DM | -0.716 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.174 | NR-AR-LBD | 0.206 |
NR-AhR | 0.003 | NR-Aromatase | 0.021 |
NR-ER | 0.238 | NR-ER-LBD | 0.404 |
NR-PPAR-gamma | 0.174 | SR-ARE | 0.131 |
SR-ATAD5 | 0.304 | SR-HSE | 0.182 |
SR-MMP | 0.008 | SR-p53 | 0.027 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.